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Abstract. In  o r d e r  to assess the  poss ib le  effects o f  
centra l  G A B A  ac t iva t ion  on  the conso l i da t i on  o f  
shock avoidance ,  the G A B A - T  inh ib i to r  amino-oxy-  
acet ic  acid  ( A O A A )  was admin i s t e red  pos t t r i a l  to 
adu l t  male  rats .  Lea rn ing  was assessed over  nine  
widely  spaced  sessions o f  20 tr ials  each. A O A A -  
t rea ted  an imals  showed learn ing  wi th in  sessions and  
a lack  o f  conso l i da t i on  across  sessions. Cont ro l s ,  on 
the o ther  hand ,  showed learn ing  bo th  wi thin  and 
across  sessions. This  evidence agrees  with p rev ious  
repor t s  suggest ing G A B A  invo lvement  in m e m o r y  
processes.  
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M e m o r y  
A var ie ty  o f  repor t s  have suggested the invo lvement  
o f  G A B A  neurons  in m e m o r y  conso l ida t ion .  On the 
one hand ,  p ic ro tox in ,  a b locke r  o f  G A B A  neuro t rans -  
miss ion,  r epo r t ed ly  faci l i ta tes  the acquis i t ion  o f  maze  
learn ing  and  o the r  l ea rn ing  tasks  (e.g., Breen and  
M c G a u g h ,  1961; Garg ,  1970; for  m o r e  extensive 
reviews see Essman,  1971; D a w s o n  and  M c G a u g h ,  
1973). O n  the o the r  hand ,  a n u m b e r  o f  repor t s  have 
fai led to repl ica te  this f inding (see above  reviews),  and  
local ized C N S  in jec t ions  o f  G A B A  blockers  m a y  
interfere  wi th  r a the r  than  faci l i ta te  conso l i da t i on  
( K i m  and  Rou t t enbe rg ,  1976). In  add i t ion ,  a n u m b e r  
o f  cl inical  r epor t s  have  suggested tha t  enhancemen t  
o f  g a m m a - a m i n o b u t y r i c  acid  ( G A B A )  by  chemo-  
the rapy  m a y  improve  the lea rn ing  abi l i ty  o f  r e t a rded  
or  emo t iona l l y  d i s tu rbed  ch i ldren  (De Souza  C o m p o s ,  
1968; Rossi ,  1972). 
N o  studies to date ,  to  our  knowledge ,  have 
examined  the effects o f  G A B A  enhancemen t  on 
m e m o r y  conso l i da t i on  in animals .  The  present  r epo r t  
therefore  a t t e m p t e d  to affect l ea rn ing  t h rough  such 
means .  The  drug  used was amino-oxyace t i c  acid  
( A O A A ) ,  an  inh ib i to r  o f  G A B A  ca t abo l i sm  (Perry  
and  Hansen ,  1973; G r i m m  et al., 1975), and  its effects 
were examined  on two-way  shu t t l ebox  avo idance  
learning,  a t ask  of ten used in conso l ida t ion  experi-  
ments .  
M A T E R I A L S  A N D  M E T H O D S  
Subjects. Subjects were 17 adult male Sprague Dawley rats (Charles 
River Farms, Portage, MI), each weighing 350-550 g. All subjects 
were housed individually with food and water available ad libitum 
and normal lighting cycles of 12 h. Two experimental and three 
control animals were eliminated from the experiment during the 
course of testing because one subject died due to causes unrelated 
to the experiment, two learned an avoidance response that could 
not be measured by the designated shuttle response (i.e., perching 
upon a central barrier), and two showed experimental helplessness 
(i.e., a failure to learn to escape from shock in any trial). The final 
pool, therefore, consisted of seven experimental and five control 
animals. 
Apparatus. Subjects were tested in a 27 x 22 • 48 cm shuttlebox 
(BSR/LVE No. 146/04) situated in an anechoic chamber to 
minimize experimental interference. The CS was provided by an 
overhead sonalert alarm, which emitted a 2.5 kHz tone. 
Drugs. Amino-oxyacetic acid (Sigma 4508) was administered 25 nag/ 
kg immediately (i.e., less than 60 s) after each session, and control 
rats received a vehicle injection in an identical manner. All injections 
were administered i.p. 1 ml/kg in 0.9% sodium chloride solution. 
Drug dosage was based on previous biochemical and behavioral 
studies (e.g., Grimm et al., 1975; Wood and Peesker, 1973). 
Procedure. Subjects were given 20 trials per day for nine sessions. 
Each trial consisted of a 5-s CS (tone) followed by a 30-s US 
(pulsed shock). The shock US consisted of 15 regularly spaced 
0.5 s pulses of 0.75 mA scrambled AC current delivered by LVE 
113-33 shockers. Intertrial intervals ranged from 30 s to 3 min. 
A minimum of 72 h intervened between sessions. 
Statistical Analysis. Learning curves for both experimental and 
control groups are presented as means and standard errors in 
Figure 1. For ease of presentation and analysis, data are grouped 
into five trial blocks, four per session. Initial visual inspection of 
the learning curves indicated a large difference in SE scores across 
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Fig. 1, Effects of posttrial AOAA on shuttlebox shock avoidance. Points: mean + SEM for number of shocks in five trial blocks during 
same session. Solid lines: AOAA-treated. Broken lines: vehicle-treated 
testing conditions. Analysis was therefore based on the distribution- 
free technique of Jonckheere (1954) against ordered alternatives. 
It might be noted that the Jonckheere technique specifically assesses 
the ordering of events and thus is particularly appropriate for the 
analysis of learning or other processes in which sequential outcome 
is a consideration. 
Statistical assessment of learning within sessions indicated 
substantial learning by both groups (S values = 95, 83, respec- 
tively, for experimental and control groups P < 0.01). Learning 
across sessions was tested by Jonckheere analysis upon the 
ordering of the initial block of trials of each session across the nine 
learning sessions, with the assumption that learning across sessions 
should result in an ordered decrease within this block. As Figure 1 
indicates, the experimental group shows only marginal learning 
(S = 8, P > 0.05) while the vehicle-treated group shows evidence 
of learning across sessions (S = 35, P < 0.01). 
DISCUSSION 
It is apparent  that both groups of  subjects showed con- 
siderable learning within sessions. It is also clear, 
however, that in the experimental animals the admin- 
istration of AOAA after a learning session produced 
a dramatic disruption of learning across sessions. This 
suggests that A O A A  is a potent amnesia-producing 
drug. It  might be argued, however, that the AOAA- 
treated group was disadvantaged due to processes 
unrelated to memory  functions. For  example, AOAA 
may produce ataxia in rats (Gr imm et al., 1975), but 
AOAA-treated rats were not drugged during learning, 
and sufficient time elapsed between sessions for drug 
effects to dissipate. An inspection of  the learning 
curves clearly indicates that the motor  performance 
of the experimental animals was sufficient for sub- 
stantial learning within sessions. Thus the lack of 
across-sessions learning may represent interference 
with the formation of long-term memory.  
The ability of  GABA-enhancing agents to decrease 
consolidation agrees with and complements the ability 
of  G A B A  blockers to facilitate consolidation (e.g., 
Breen and McGaugh,  1961; Garg, 1970), although it 
is not necessarily consistent with clinical reports of  
GABA-induced memory  enhancement (De Souza 
Campos,  1968; Rossi, 1972). These clinical reports 
often involved the concurrent administration of other 
drugs and the systemic administration of GABA itself 
as a dietary suppliment. GABA, however, is not 
believed to cross the blood brain barrier (Perry and 
Hansen, 1973). Finally, the clinical studies suffered 
f rom a number  of  methodological insufficiencies; 
i.e., they were not run in a double-blind design, nor 
did they examine consolidation as a separate experi- 
mental  variable. Thus they may not be strictly com- 
parable to the current results. 
One other question might be raised regarding the 
biochemical specificity of  GABA's  anticonsolidation 
effect. GABA levels in the brain are not maximally 
increased until 4 h after injection (Gr imm et al., 1975), 
and this implies a prolonged vulnerability of  the 
memory  trace. It might therefore be asked if a time 
course of  consolidation of several hours is physiolo- 
gically reasonable. Wood and Peesker (1973) have 
noted that G A B A  elevations are significant at 1 h, 
although they subsequently continue to increase. 
Assuming that a significant albeit less than maximal 
increase in GABA is effective, a 1- rather than 4-h 
memory  course must be accounted for. We feel a vul- 
nerability of  1 - 2 h is reasonable in light of  other evi- 
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dence showing consolidation effects of several hours 
with many treatments (e.g., 1 h, Schneider et al, 1969; 
3 - 6 h ,  Barondes and Cohen, 1968; 6h,  Cherkin, 
1969; 24 h, Flexner et al., 1963). While shorter critical 
consolidation periods are also well established, these 
depend, as above, on model, treatment, and species. 
No a priori limit on consolidation time holds across 
conditions, and the present findings do not exceed 
the limits established by other treatments. 
Heretofore, only limited attention has been devoted 
to the CNS events underlying GABA blockade or 
facilitation in relation to long-term memory effects. 
Recent histochemical and electrophysiological data 
may, however, offer some insight. It has been estab- 
lished that GABA may decrease the turnover of CNS 
noradrenergic and dopaminergic neurons (Fuxe et al., 
1975). This turnover effect presumably depends on 
presynaptic (possibly axo-axonic) inhibition of mono- 
aminergic cells (Suria and Costa, 1975). 
Recently, it has also been shown that central NA 
neurons may mediate memory consolidation in the 
rat (e.g., Stein, 1975). If the observed experimental 
differences are a function of central GABA-NA inter- 
actions, it should be possible to reverse AOAA 
amnesia with clonidine or to reverse picrotoxin 
memory enhancement with phenoxybenzamine. We 
know of no published work addressing either of these 
hypotheses concerning GABA's pharmacological 
mode of action. 
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